Generic Name: leuprolide / norethindrone
Common side effects of Lupaneta Pack include: depression and migraine.  See below for a comprehensive list of adverse effects.
Applies to leuprolide / norethindrone: powder for suspension 1 month, powder for suspension 3 month, tablet
In addition to its needed effects, some unwanted effects may be caused by leuprolide / norethindrone. In the event that any of these side effects do occur, they may require medical attention.

If any of the following side effects occur while taking leuprolide / norethindrone, check with your doctor or nurse immediately:
Some of the side effects that can occur with leuprolide / norethindrone may not need medical attention. As your body adjusts to the medicine during treatment these side effects may go away. Your health care professional may also be able to tell you about ways to reduce or prevent some of these side effects. If any of the following side effects continue, are bothersome or if you have any questions about them, check with your health care professional:


Applies to leuprolide / norethindrone: oral and injectable kit
The most common adverse reactions leading to discontinuation of therapy included hot flashes (4%), emotional lability (4%), depression (4%) and acne (2%).The most common adverse reaction observed were hot flashes and headaches.[Ref]
Leuprolide-Norethindrone:Very common (10% or more): Hot flashes/sweats (up to 87%)Leuprolide:Very common (10% or more): Hot flashes/sweats (98%)Postmarketing reports: Hypotension, hypertension, serious venous and arterial thrombotic and thromboembolic events (deep vein thrombosis, pulmonary embolism, myocardial infarction, stroke, transient ischemic attack[Ref]
Leuprolide-Norethindrone:Very common (10% or more): Androgen-like effects (acne, alopecia) (up to 18%), skin/mucous membrane reaction (up to 11%)Leuprolide:Common (1% to 10%): Androgen-like effects (acne, alopecia) (4%), skin/mucous membrane reaction (4%)[Ref]
Leuprolide-Norethindrone:Very common (10% or more): Altered bowel function (constipation, diarrhea) (up to 15%), nausea/vomiting (up to 29%)Common (1% to 10%): GI disturbances (dyspepsia, flatulence) (up to 7%), changes in appetite (6%)Leuprolide:Very common (10% or more): Nausea/vomiting (25%), altered bowel function (constipation, diarrhea) (14%)Common (1% to 10%): Changes in appetite (4%)%), GI disturbances (dyspepsia, flatulence) (4%)[Ref]
Leuprolide-Norethindrone:Very common (10% or more): Vaginitis (up to 15%%), breast changes/pain/tenderness (up to 13%)Common (1% to 10%): Menstrual disorders (5%)Frequency not reported: Urinary tract infectionLeuprolide:Very common (10% or more): Vaginitis (20%)Common (1% to 10%): Breast changes/pain/tenderness (6%), menstrual disorders (2%)[Ref]
Leuprolide:Postmarketing reports: Decreased white blood count[Ref]
Leuprolide:Postmarketing reports: Serious liver injuryLeuprolide-Norethindrone:Common (1% to 10%): Elevated SGPT (at least twice the upper limit) (2%), elevated GGT (1.5%)[Ref]
Leuprolide-Norethindrone:Postmarketing reports: Allergic reactions (anaphylactic, rash, urticaria, photosensitivity)[Ref]
Leuprolide-Norethindrone:Common (1% to 10%): Injection site reaction (up to 9%)Leuprolide:Common (1% to 10%): Injection site reaction (2%)Postmarketing reports: Localized reactions including induration and abscess at the site of injection[Ref]
Leuprolide-Norethindrone:Very common (10% or more): Weight gain (up to 13%)Common (1% to 10%): Edema (up to 9%), elevated SGPT (at least twice the upper limit) (2%), elevated GGT (1.5%)Frequency not reported: Increased total cholesterol (greater than 240 mg/dL), decreased HDL cholesterol (less than 40 mg/dL), increased LDL cholesterol (greater than 160 mg/dL), increased LDL/HDL ratio (greater than 4), increased triglycerides (greater than 200 mg/dL)Leuprolide:Common (1% to 10%): Weight gain (12%)[Ref]
Leuprolide:Postmarketing reports: Spinal fracture, tenosynovitis-like symptoms, symptoms consistent with fibromyalgia[Ref]
Leuprolide-Norethindrone:Very common (10% or more): Headache/migraine (up to 51%), insomnia/sleep disorders (up to 15%), dizziness/vertigo (up to 11%)Common (1% to 10%): Neuromuscular disorder (leg cramps, paresthesia) (up to 9%), decreased libido (up to 7%), memory disorder (up to 4%)Leuprolide:Very common (10% or more): Headache/migraine (65%), insomnia/sleep disorders (31%), dizziness/vertigo (16%), decreased libido (10%)Common (1% to 10%): Memory disorder (6%), neuromuscular disorder (leg cramps, paresthesia) (2%)Postmarketing reports: Pituitary apoplexy, convulsion, peripheral neuropathy, paralysis[Ref]
Leuprolide-Norethindrone:Very common (10% or more): Pain (up to 29%), asthenia (up to 18%)Leuprolide:Very common (10% or more): Pain (24%), asthenia (18%)
Leuprolide-Norethindrone:Very common (10% or more): Depression/emotional lability (up to 34%), nervousness/anxiety (up to 11%)Leuprolide:Very common (10% or more): Depression/emotional lability (31%)Common (1% to 10%): Nervousness/anxiety (8%)Postmarketing reports: Mood swings, suicidal ideation and attempt[Ref]
Leuprolide-Norethindrone:Frequency not reported: Renal calculus[Ref]
Leuprolide:Postmarketing reports: Symptoms consistent with an asthmatic process[Ref]
1. "Product Information. Lupaneta Pack (leuprolide-norethindrone)." Abbott Pharmaceutical, Abbott Park, IL. 
Not all side effects for Lupaneta Pack may be reported. You should always consult a doctor or healthcare professional for medical advice. Side effects can be reported to the FDA here.

Crying
depersonalization
dysphoria
euphoria
feeling of warmth
mental depression
paranoia
quick to react or overreact emotionally
rapidly changing moods
redness of the face, neck, arms, and occasionally, upper chest
sudden sweating
swelling


Anxiety
bladder pain
bloody or cloudy urine
blurred vision
chest pain
confusion
convulsions
cough
dark urine
difficult, burning, or painful urination
difficulty speaking
difficulty swallowing
dizziness or lightheadedness
double vision
fainting
fast heartbeat
flu-like symptoms
frequent urge to urinate
headache
hives or welts
inability to move the arms, legs, or facial muscles
increased sensitivity of the skin to sunlight
itching
joint or muscle pain or stiffness
lower back or side pain
nausea and vomiting
numbness or tingling in the face, arms, or legs
pain in the groin or genitals
pain, redness, or swelling in the arm or leg
pounding in the ears
puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
redness of the skin
right upper quadrant tenderness
severe sunburn
sharp back pain just below the ribs
skin rash
slow or fast heartbeat
slow speech
sudden shortness of breath or trouble breathing
sweating
thoughts or attempts at killing oneself
tightness in the chest
trouble breathing
trouble sleeping
trouble thinking or walking
unusual tiredness or weakness
yellow eyes or skin


Acid or sour stomach
being forgetful
belching
bleeding, blistering, burning, coldness, discoloration of the skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, pain, rash, redness, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at the injection site
blemishes on the skin
bloated or full feeling
burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings
changes in appetite
decreased interest in sexual intercourse
diarrhea
difficulty having a bowel movement (stool)
excess air or gas in the stomach or intestines
feeling of constant movement of self or surroundings
hair loss or thinning of the hair
headache, severe and throbbing
heartburn
inability to have or keep an erection
indigestion
lack or loss of strength
loss in sexual ability, desire, drive, or performance
pain or tenderness from the breasts
passing gas
pimples
sensation of spinning
stomach discomfort, upset, or pain
weight gain


Absent missed or irregular menstrual periods
itching of the vagina or genital area
pain during sexual intercourse
stopping of menstrual bleeding
thick, white vaginal discharge with no odor or with a mild odor

